Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) hsv:(Cancer och onkologi) srt2:(2000-2004)"

Sökning: hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) hsv:(Cancer och onkologi) > (2000-2004)

Sortera/gruppera träfflistan
  • Priftakis, Peter, et al. (författare)
  • Human polyomavirus DNA is not detected in Guthrie cards (dried blood spots) from children who developed acute lymphoblastic leukemia
  • 2003
  • Ingår i: Medical and Pediatric Oncology. - 0098-1532 .- 1096-911X. ; 40:4, s. 219-223
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Background</p> <p>Epidemiological evidence has suggested that some childhood acute lymphoblastic leukemia (ALL) may be initiated in utero and may have an infectious etiology. The human polyomavirus JC virus (JCV) has been discussed as a candidate virus, but its presence has not been demonstrated in leukemia cells from children with ALL. The aim of this study was, therefore, to investigate if prenatal human polyomavirus infection could still indirectly be correlated to the development of childhood ALL.</p> <p>Procedure</p> <p>Fifty-four Guthrie cards (stored, dried blood spots filter papers, routinely collected from newborns for different screening analyses), collected at 3–5 days of age, from Swedish children who subsequently developed ALL, as well as from 37 healthy controls, were investigated by nested PCR for the presence of human polyomaviruses JCV and BK virus (BKV).</p> <p>Results</p> <p>JCV and BKV DNA were not detected in any of the Guthrie cards from ALL patients or from healthy controls, although all tested samples had amplifiable DNA as confirmed by an HLA DQ PCR.</p> <p>Conclusions</p> <p>JCV or BKV were not found in any of the dried blood spots of children who later developed ALL or in the healthy controls. These findings suggest that it is unlikely that childhood ALL is associated with an in utero infection with JCV or BKV, although it is not possible to exclude an association with an in utero infection that has become latent in the kidneys with very low levels of circulating virus at birth.</p>
  • Relander, Thomas, et al. (författare)
  • Retroviral transduction of human CD34+ cells on fibronectin fragment CH-296 is inhibited by high concentrations of vector containing medium
  • 2001
  • Ingår i: Journal of Gene Medicine. - John Wiley and Sons Inc.. - 1521-2254. ; 3:3, s. 207-218
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: The objective of the present study was to optimize conditions for retroviral transduction of human cord blood (CB) CD34+ cells and to reveal mechanisms which interfere with efficient gene transfer. METHODS: An MSCV based retroviral vector with the gene for enhanced green fluorescent protein (MGIN) produced by GP+envAM12 (amphotropic envelope), PG13 (gibbon ape leukemia virus envelope) or 293GPG (vesicular stomatitis virus envelope) cell lines was used to transduce cord blood CD34+ cells on Retronectin (fibronectin fragment CH-296) in three different ways: either in vector containing medium (VCM), in fresh medium on Retronectin pre-loaded with vector or in VCM on Retronectin pre-loaded with vector. RESULTS: Paradoxically, the transduction efficiency obtained with pre-load of vector onto Retronectin alone was higher than pre-load plus VCM for PG13-MGIN (67.9 +/- 6.0% vs 24.9 +/- 8.0%) and AM12-MGIN (47.5 +/- 5.8% vs 38.7 +/- 2.2%). Further experiments showed that transduction on Retronectin pre-loaded with PG13-MGIN or AM12-MGIN was inhibited by the presence of the same VCM at high concentrations, but not by the presence of a VCM with a different receptor specificity. If no pre-load of vector was performed, the highest transduction efficiencies were seen when VCMs were diluted 1:10 (MOIs of 3). The inhibitory effect of high titer PG13-MGIN VCM was confirmed in more primitive CD34+CD38low cells and in NOD/SCID repopulating cells, and was also seen in experiments with bone marrow CD34+ cells. CONCLUSIONS: Retroviral transduction of CB CD34+ cells on Retronectin is inhibited by high titer PG13 and GP+envAM12 vector containing medium. Efficient gene transfer to human hematopoietic cells can be obtained by preload alone of the vector onto Retronectin. These findings are of importance for the design of transduction protocols for repopulating hematopoietic cells.
  • Ringberg, Anita, et al. (författare)
  • Accrual rate-limiting factors in a Swedish randomised ductal carcinoma in situ (DCIS) trial - a demographic study
  • 2000
  • Ingår i: European Journal of Cancer. - Elsevier. - 1879-0852. ; 36:4, s. 483-488
  • Tidskriftsartikel (refereegranskat)abstract
    • In the last two decades the introduction of mammographic screening in the Western world has increased the number of diagnosed ductal carcinomas in situ (DCIS) considerably. In situ carcinoma of the breast is considered a heterogeneous disease, the natural history of which is not well known. Thus, appropriate treatment needs to be established. For this reason, a randomised trial studying the effect of breast conserving operation with or without postoperative radiotherapy was instituted in Southern Sweden in 1987. The aim of the present study was to assess patient accrual, identify limiting factors, and evaluate possible ways to influence these factors in order to increase patient accrual. Between 1987 and 1992, 331 patients had been registered with DCIS in the Regional Tumour Registry, 96 of which had been randomised. All 331 were subjected to chart review studying clinical data, mammography reports, cytology and pathology reports to identify inclusion and exclusion criteria according to the design of the trial. It was found that 5% (18/331) had an incorrect diagnosis of DCIS. According to the trial protocol 52% were not eligible (162/313). Fifty-eight per cent (n=88) of the 151 eligible patients had been correctly randomised. The most common reason for exclusion was lesion size. In 21% (66/313) the lesion was 'too large'. Several other limiting factors were identified such as in cytological and pathological definitions and reports, lack of information/awareness in certain physicians, patient reluctance to participate, which in turn may be influenced by the previous factor. With increased information to participating hospitals and considering the above given facts it should be possible to increase accrual from the 28% noted in the present consecutive demographic study to at least one-third of the diagnosed cases of DCIS.
  • Ringberg, Anita, et al. (författare)
  • Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast
  • 2000
  • Ingår i: European Journal of Surgical Oncology. - Elsevier. - 1532-2157. ; 26:5, s. 444-451
  • Tidskriftsartikel (refereegranskat)abstract
    • METHOD AND RESULTS: A standardized histopathological protocol has been designed, in which different histological characteristics of ductal carcinoma in situ (DCIS) are reported: nuclear grade (ng), growth pattern according to Andersen et al., necrosis, size of the lesion, resection margins and focality. Using this protocol a re-evaluation of a population-based consecutive series of 306 cases of DCIS has been done as well as a thorough clinical follow-up. After a median follow-up of 63 months, 13% have developed ipsilateral local recurrences, invasive and/or in situ. Ipsilateral local recurrence-free survival (IL-RFS) was significantly better for patients operated with mastectomy (ME) or breast conserving therapy (BCT) with radiotherapy (RT) than for patients operated with BCT without RT (5-year IL-RFS 96% vs 94% vs 79%, P<0.001). In the subgroup of BCT without RT there were significant differences in IL-RFS between histopathological subgroups: ng 1 + 2 (non-high grade) vs ng 3 (high grade; P=0.014), non-high-grade without comedo-type necrosis vs non-high-grade with comedo-type necrosis vs high-grade (the Van Nuys classification system; P=0.025). Growth pattern (not diffuse vs diffuse) and margins (free vs involved or not evaluated) showed a tendency (P=0.07 and 0.05, respectively) to be associated to IL-RFS. In contrast, no significant differences in IL-RFS were found in subgroups based on mode of detection, focality or size. Ninety-four per cent of the local recurrences after BCT appeared at the previous operation site. CONCLUSIONS: In the BCT without RT group, combinations of either non-high grade and not a diffuse growth pattern or non-high grade and free margins identified groups (constituting approximately 30% of the patients) were at low risk of developing ipsilateral recurrences (6-10%), compared to a 31-37% recurrence risk in the remaining groups during the observed follow-up time. The beneficial effect of post-operative RT for these low-risk groups can be questioned, and should be studied further.
  • Asp, Julia, 1973-, et al. (författare)
  • Alterations in the regulatory pathway involving p16, pRb and cdk4 in human chondrosarcoma.
  • 2001
  • Ingår i: Journal of orthopaedic research : official publication of the Orthopaedic Research Society. - 0736-0266. ; 19:1, s. 149-54
  • Tidskriftsartikel (refereegranskat)abstract
    • The G1 regulatory pathway involving p16, pRb and cdk4 in the cell cycle has been investigated in human chondrosarcoma. The protein expression of p16, pRb and cdk4 was analyzed by Western blot in cultured cells from eight chondrosarcomas and in two chondrosarcoma cell lines. Both cell lines and one other sample were negative for p16. Moreover, one of the cell lines was pRb-negative and showed a high expression of cdk4 as well. In the other cell line and in three other samples pRb of expected size were detected in addition to a shorter form of the protein. To further investigate the reasons for down-regulation of the p16 protein, the p16-coding gene CDKN2 was analyzed by polymerase chain reaction (PCR), methyl-specific PCR (MSP) and sequencing in all tumor samples as well as in corresponding tumor tissues from three of the samples. The p16-negative samples were all found to have homozygous deletion of CDKN2. Another sample showed partial gene methylation and a heterozygous position in codon 148 was detected in one sample. The same base substitution was also found in two of the tissue samples. Finally, cytogenetic analysis of the samples with homozygously deleted CDKN2 revealed multiple structural abnormalities in all three cases. In conclusion, the p16/pRb/cdk4 pathway may play an important role in the pathogenesis of some chondrosarcomas.
  • Asp, Julia, 1973-, et al. (författare)
  • Changes in p14(ARF) do not play a primary role in human chondrosarcoma tissues.
  • 2001
  • Ingår i: International journal of cancer. Journal international du cancer. - 0020-7136. ; 93:5, s. 703-5
  • Tidskriftsartikel (refereegranskat)abstract
    • The locus encoding the tumor suppressor p16 has been found to code for a second, different protein. This protein, p14(ARF), has been shown to protect p53 from degradation. Like p16, its gene is often altered in different cancers. In this study, the first unique exon, exon 1 beta, of p14(ARF), has been studied in 22 chondrosarcoma tissues using polymerase chain reaction, DNA sequencing and methylation-specific polymerase chain reaction. One chondrosarcoma was found to have exon 1 beta homozygously deleted, but neither mutations nor methylations were found in any of the chondrosarcomas. This indicates that genetic changes of p14(ARF) are a rare event in chondrosarcoma.
  • Asp, Julia, 1973-, et al. (författare)
  • Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues.
  • 2000
  • Ingår i: International journal of cancer. Journal international du cancer. - 0020-7136. ; 85:6, s. 782-6
  • Tidskriftsartikel (refereegranskat)abstract
    • The role of two important tumour suppressor genes, p16 and p53, was evaluated in cartilaginous tumour tissues. Genomic DNA from 22 chondrosarcomas, 5 benign chondroid tumours, 1 sample of reactive proliferative cartilage and 2 samples of normal cartilage were analysed using polymerase chain reaction, single strand conformational polymorphism, DNA sequencing and methylation-specific polymerase chain reaction. The p16 gene was found to be partly methylated in 5 high-grade chondrosarcomas and homozygously deleted in 1 chondrosarcoma. Moreover, a polymorphism was detected in 3 malignant tumours, but not in benign tumours or normal cartilage. Analysis of the p53 gene revealed an unchanged structure in all samples. These findings show a role for p16, but not p53, in chondrosarcoma.
Skapa referenser, mejla, bekava och länka
fritt online (241)
Typ av publikation
tidskriftsartikel (887)
doktorsavhandling (74)
konferensbidrag (22)
forskningsöversikt (20)
bokkapitel (12)
rapport (1)
visa fler...
annan publikation (1)
visa färre...
Typ av innehåll
refereegranskat (912)
övrigt vetenskapligt (145)
populärvet., debatt m.m. (1)
Olsson, Håkan, (50)
Borg, Åke, (44)
Li, Xinjun, (33)
Fernö, Mårten, (30)
Mertens, Fredrik, (30)
Möller, Torgil, (28)
visa fler...
Bendahl, Pär Ola, (26)
Hemminki, K (22)
Baldetorp, Bo, (21)
Berglund, Göran, (21)
Landberg, Göran, (19)
Nilbert, Mef, (19)
Anderson, Harald (18)
Glimelius, Bengt, (17)
Larsson, Christer, (17)
Påhlman, Sven, (17)
Hemminki, Kari, (17)
Åkerman, Måns, (16)
Tennvall, Jan, (16)
Dillner, Joakim, (15)
Hultborn, Ragnar, 19 ... (14)
Svanberg, Katarina, (14)
Lennernäs, Bo, 1963- ... (14)
Alvegård, Thor, (14)
Dillner, J, (13)
Mertens, F, (13)
Axelson, Håkan (13)
Ahlman, Håkan, 1947- ... (13)
Strand, Sven-Erik, (13)
Gustafson, Pelle, (13)
Glimelius, B, (12)
Wängberg, Bo, 1953-, (12)
Ringnér, Markus, (12)
Stenram, Unne, (11)
Naredi, Peter, 1955- ... (11)
Manjer, Jonas, (11)
Svanberg, Sune, (11)
Mitelman, Felix, (11)
Rydholm, Anders, (11)
Karlsson, Mats G, 19 ... (11)
Blomqvist, Carl (10)
Andersson-Engels, St ... (10)
Nilsson, Ola, 1957-, (10)
Olsson, H., (10)
Mattsson, Sören, (10)
Hallmans, G (10)
Albertsson, Maria (10)
Härkönen, Pirkko, (10)
Janzon, Lars, (10)
Dictor, Michael, (10)
visa färre...
Lunds universitet (706)
Göteborgs universitet (134)
Karolinska Institutet (117)
Uppsala universitet (79)
Umeå universitet (42)
Örebro universitet (27)
visa fler...
Linköpings universitet (22)
Stockholms universitet (9)
Södertörns högskola (3)
Kungliga Tekniska Högskolan (2)
Högskolan i Jönköping (2)
Chalmers tekniska högskola (2)
Högskolan i Halmstad (1)
Linnéuniversitetet (1)
Högskolan i Gävle (1)
Ersta Sköndal Bräcke högskola (1)
visa färre...
Engelska (1003)
Svenska (12)
Kinesiska (1)
Annat språk (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (1017)
Naturvetenskap (10)
Teknik (2)
Samhällsvetenskap (1)
Humaniora (1)


pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy